SANTA CLARA, Calif.-- (BUSINESS WIRE)-- Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced U.S. Food and Drug Administration (FDA) approval of its ...
JONESBORO, Ark. (Edited News Release/KAIT) - The Centers for Medicare & Medicaid Services (CMS) recently certified the Advanced Heart Surgery Program at St. Bernards Medical Center to implant ...
On the heels of enrolling the first patient in a pivotal trial of a ventricular restoration system to treat symptomatic heart failure patients in January, Ancora Heart Inc. closed $80 million in new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results